Each year, the Pharmapack Awards recognize new products that are set to shape the future of the industry, developed by the most innovative companies
February 2019
The annual Pharmapack Paris is one of the most comprehensive European events for Pharmaceutical Packaging, Drug Delivery, Medical Devices and Machinery. Besides a rich conference program, symposiums and workshops, the Pharmapack Awards is a returning highlight: a ceremony that since 1997 has been recognizing breakthrough products that hold a strong potential to shape the future of the industry.
This year Stevanato Group presented the integration of its capabilities through its cartridge-based wearable device, which won the Pharmapack Awards as the Best Innovation in Drug Delivery Device. The product has been developed to respond to the increasing demand for advanced drug delivery systems that can offer convenience and ease of administration for patients who need intuitive, discreet and easy-to-use devices. Stevanato Group’s cartridge-based wearable device ensures also the pharmaceutical companies an innovative approach in the pen market through a more user-friendly system that guarantees both product reliability and patient safety.
“This year is Stevanato Group’s 70th anniversary and I think it is very fitting that we are here at Pharmapack to now talk more about devices and integrated solutions. Thanks to the hard-working dedication of Irio Calasso and his team, together with our team in Italy and in the rest of the world, we have been able to bring this type of innovative technology forward,” commented Steven Kaufman, Vice President of Drug Delivery Systems at Stevanato Group, after receiving the trophy at the Awards ceremony.
12.02.2019, Stevanato Group
News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.